Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Seminars in Immunology|October 12, 2015
Contribution of metabolic reprogramming to macrophage plasticity and functionKarim C El Kasmi, Kurt R Stenmark
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 2, 2015
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertensionKurt R Stenmark, Rubin M Tuder, Karim C El Kasmi
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 23, 2014
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypesSteven C Pugliese, Jens M Poth, Mehdi A Fini, et al.
Antioxidants & Redox Signaling|June 23, 2017
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic ReprogrammingAngelo D'Alessandro, Karim C El Kasmi, Lydie Plecitá-Hlavatá, et al.
Annual Review of Physiology|December 11, 2012
The adventitia: essential regulator of vascular wall structure and functionKurt R Stenmark, Michael E Yeager, Karim C El Kasmi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2017
A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary HypertensionSteven C Pugliese, Sushil Kumar, William J Janssen, et al.
American Journal of Respiratory Cell and Molecular Biology|December 25, 2015
Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary HypertensionLydie Plecitá-Hlavatá, Jan Tauber, Min Li, et al.
American Journal of Surgery|August 24, 2017
Cancer-promoting mechanisms of tumor-associated neutrophilsBrian Hurt, Richard Schulick, Barish Edil, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 11, 2010
Emerging therapies for the treatment of pulmonary hypertensionKurt R Stenmark, Marlene Rabinovitch
Pageof 26